...
首页> 外文期刊>British Journal of Haematology >An introduction to induced pluripotent stem cells.
【24h】

An introduction to induced pluripotent stem cells.

机译:诱导多能干细胞简介。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Recent landmark studies show that it is now possible to convert somatic cells, such as skin fibroblasts and B lymphocytes, into pluripotent stem cells that closely resemble embryonic stem cells. These induced pluripotent stem (iPS) cells can be generated without using human embryos or oocytes, thus bypassing some of the ethical issues that have limited the use of human embryonic stems (hES) cells. Additionally, they can be derived from the patient to be treated, thereby overcoming problems of immunological rejection associated with the use of allogeneic hES cell derived progenitors. Whilst these patient-specific iPS cells have great clinical potential, their immediate utility is likely to be in drug screening and for understanding the disease process. This review discusses the promise of iPS cells as well as the challenges to their use in the clinic.
机译:最近的标志性研究表明,现在有可能将诸如皮肤成纤维细胞和B淋巴细胞的体细胞转化为与胚胎干细胞非常相似的多能干细胞。这些诱导的多能干(iPS)细胞可以在不使用人类胚胎或卵母细胞的情况下生成,从而绕开了一些限制人类胚胎干(hES)细胞使用的伦理问题。另外,它们可以源自待治疗的患者,从而克服了与使用同种异体hES细胞来源的祖细胞相关的免疫排斥问题。尽管这些患者特异性iPS细胞具有巨大的临床潜力,但它们的直接用途可能是用于药物筛选和了解疾病过程。这篇评论讨论了iPS细胞的前景以及在临床中使用它们的挑战。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号